SpeedWeed

JULY 23, 2021

Denver is expanding Alzheimer’s research through the efforts of local company MedPharm. . The company plans to move forward with research efforts through a special Schedule I Researcher Licenses given specifically to the company by the Drug Enforcement Administration. Denver Company Moves Forward with Research License .

Clinical Trials 52

Clinical Trials Research and Development DEA Cannabinoids 52

Cannabis Law Report

MARCH 25, 2020

SAN DIEGO , March 24, 2020 /PRNewswire/ — Medical Marijuana, Inc. (OTC: OTCQB: AXIM) (“AXIM® Biotech” or “AXIM”) has completed the acquisition of leading oncology research and development company Sapphire Biotech, Inc. (“Sapphire”). CEO Dr. Stuart Titus. CEO Dr. Stuart Titus.

Research and Development 59

Research and Development Supply Chain Pharmaceutical Clinical Trials 59

Veriheal

APRIL 11, 2022

federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD. Orphan Drug Designation?

DEA 66

DEA Clinical Trials THC Research and Development 66

Cannabis Law Report

DECEMBER 9, 2021

Nue Life is donating $50,000 to MAPS and $10,000 to the Ketamine Research Foundation. “We believe it is the responsibility of psychedelic-therapy companies to provide material support to the life-changing research being done in the space, which has made our work possible. . MIAMI , Dec.

Research and Development 52

Research and Development Therapy Clinical Trials Treatment 52

CannaMD

MAY 25, 2021

In recent years, research has revealed that two of marijuana’s two major cannabinoids — THC and CBD — can interact with the human endocannabinoid system to influence bone healing and regeneration. At the four week mark and beyond, however, this trend reversed, resulting in an increase in new bone development.

Marijuana 111

Marijuana Research and Development Clinical Trials THC 111

MMJ Recs

DECEMBER 28, 2023

In recent years, a significant shift has occurred in the perception of medical marijuana, transforming it from a controversial substance to a recognized and, in some places, a legal form of medical treatment. Medical marijuana, however, has emerged as a potential alternative.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

Veriheal

MAY 3, 2022

A recent study , funded by the National Institute on Drug Abuse (NIDA) and published in JAMA Network Open , reported a correlation between obtaining a medical marijuana (MMJ) card and developing CUD. Despite being published in a reputable journal, there are questions about the legitimacy of the research.

Research and Development 98

Research and Development Clinical Trials Consumption Patients 98

Veriheal

OCTOBER 20, 2023

Commissioner Nick Ciaramitaro further argued that the “Use of marijuana on the job is different than having used it months before you take the test.” The vote represents the employees’ desire for fair treatment and recognition for their efforts within the industry. The policy change only affects pre-employment drug screening.

Policy 106

Policy Clinical Trials Research and Development Dispensary 106

Puff Puff Post

JANUARY 13, 2020

Now that retailers broadly sell CBD oil, it offers a number of challenges and opportunities to medical researchers. Preliminary Research on CBD Oil. Pharmacies, as more profitable companies, have the resources to research the other cannabinoids present in CBD oil. Cannabidiol As Treatment For Opiate and Alcohol Addiction.

CBD 52

CBD Clinical Trials Research and Development Oil 52

Puff Puff Post

JANUARY 13, 2020

Now that retailers broadly sell CBD oil, it offers a number of challenges and opportunities to medical researchers. Preliminary Research on CBD Oil. Pharmacies, as more profitable companies, have the resources to research the other cannabinoids present in CBD oil. Cannabidiol As Treatment For Opiate and Alcohol Addiction.

CBD 52

CBD Clinical Trials Research and Development Oil 52

Cannabis Law Report

AUGUST 9, 2021

Investors will continue to keep an eye on several ongoing clinical trials, as well as private companies that are gearing up to go public over the coming quarters. NEO: MEDI) (OTC: KONEF) signed an exclusive agreement for the use of VR technology in psychedelic treatments with OVR Tech LLC. Industry Developments.

Clinical Trials 105

Clinical Trials Decriminalization Research and Development Treatment 105

MMJ Recs

DECEMBER 22, 2023

Medical marijuana, once a controversial and stigmatized topic, has undergone a remarkable transformation in the eyes of the American public. Changing Public Opinion on Medical Marijuana in the United States In recent decades, the public’s stance on medical marijuana has shifted from skepticism to acceptance.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

SpeedWeed

SEPTEMBER 4, 2021

The DEA published a new document in the Federal Register on September 2 requesting an increase in production for certain Schedule I and Schedule II substances so that it can initiate more research studies. . DEA firmly believes in supporting regulated research of schedule I controlled substances. View original article.

DEA 52

DEA Research and Development Clinical Trials Extraction 52

SpeedWeed

SEPTEMBER 17, 2021

The funding will allow MAPS Public Benefit Corporation (MAPS PBC) to activate a team to evaluate the scope of the lack of resources needed for TBI treatment. . Wesana is a serious, thoughtful and ethical company engaged in the development of psychedelic-assisted therapy. Beyond MDMA, MAPS Pushes Psychedelic Research Forward.

Clinical Trials 53

Clinical Trials Research and Development Therapy Treatment 53

Cannabis Law Report

JUNE 24, 2022

Marijuana Moment reports. The leader of the New Jersey Senate filed a bill on Thursday that would legalize the possession, home cultivation and gifting of psilocybin mushrooms for adults 21 and older—with provisions that give adults even more freedoms for the psychedelic than are afforded under the state’s current marijuana laws.

Clinical Trials 52

Clinical Trials Legalization Research and Development Therapy 52

MMJ Recs

DECEMBER 17, 2023

The Texas Compassionate Use Program (TCUP) represents the Lone Star State’s cautious foray into the realm of medical marijuana. Current Texas Medical Marijuana Regulations CBD laws in Texas are governed by the Compassionate Use Program.

Law 52

Law Dispensary Clinical Trials Programs 52

CannaMD

JUNE 2, 2021

A new study indicates that a significant number of persons suffering from Parkinson’s disease use medical marijuana for symptom relief. The goal of the study was to gain a better understanding of not only the frequency of marijuana use by those suffering from Parkinson’s, but also their motivations for use and their experiences.

Patients 105

Patients Clinical Trials Treatment Research and Development 105

SpeedWeed

AUGUST 11, 2021

According to Dr. Sue Sisley, President of the Scottsdale Research Institute and longtime cannabis researcher, this new study is sorely needed in the community. Veterans are demanding objective cannabis drug development research, and the state of Michigan is fulfilling our collective obligation to our beloved Veteran community.”.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical DEA 52

Cannabis Law Report

JUNE 21, 2021

(OTC: EHVVF) adds Dr. Jeffrey Kamlet, an expert on cardiac safety in ibogaine treatment, as Chief Medical Officer. retains CRO Sante Cannabis to conduct clinical trials in psilocybin therapies. NEO: MYCO) plans to leverage AI and ML to accelerate its research and development. Industry Developments.

Clinical Trials 66

Clinical Trials Research and Development Therapy Pharmaceutical 66

Cannabis Law Report

OCTOBER 17, 2019

(Tree of Knowledge) (CSE:TOKI) (OTC:TOKIF) expands global medical marijuana and CBD research in partnership with the Caribbean Institute of Pharmacy Policy (CIPPPAR) in Jamaica. Tree of Knowledge will be introducing chronic pain management protocols and research into the Caribbean market.

Clinical Trials 40

Clinical Trials Research and Development Chronic Pain CBD 40

PrestoDoctor

OCTOBER 11, 2023

One area of research that has been gaining attention is the use of CBD-rich cannabis in treating the social symptoms of Autism Spectrum Disorder (ASD). Some individuals may have delayed speech development or struggle with expressing their thoughts and emotions effectively. For years, the use of cannabis has been a controversial topic.

CBD 52

CBD Research and Development Clinical Trials Treatment 52

The Joint Blog

JANUARY 31, 2021

According to a new study published in the Journal of Medical Case Reports , the daily use of high-CBD (cannabidiol) marijuana extracts is associated with improvements in the behavioral symptoms related to autism spectrum disorder (ASD). The individual was given very low-doses of marijuana extracts, no larger than 0.2 ml twice daily.

Epilepsy 62

Epilepsy Extraction Research and Development Clinical Trials 62

Greencamp

FEBRUARY 17, 2019

The science and research behind cannabis and IBS has linked the imbalances of our endocannabinoid system with certain IBS symptoms. Crohn’s Disease and Marijuana: Efficacy, Research and Dosing. In fact, the risk of developing IBS increases after a gastrointestinal infection for about 10%. Here’s how. What is IBS?

Digestion 96

Digestion Research and Development Marijuana Cannabinoids 96

Greencamp

AUGUST 16, 2018

In this comprehensive guide, we are exploring the research on using cannabis for treating Amyotrophic lateral sclerosis (ALS)—a rare neuron disease that targets the motor neurons in the body. Exploring the available research on ALS and cannabinoids. Marijuana and Epilepsy: Here’s How Cannabis Stops Seizures (12 Studies).

Strains 94

Strains Cannabinoids Research and Development Indica 94

Cannabis Law Report

JANUARY 19, 2022

During his 24 years in Congress, Congressman Moran was recognized as a champion of innovative research and development in areas including healthcare and national security, environmental protection and sustainability, and international trade and fiscal responsibility. About IGC: India Globalization Capital, Inc.

Clinical Trials 52

Clinical Trials Research and Development Education Therapy 52

Veriheal

NOVEMBER 17, 2020

But this has failed in the past and could prevent measures from moving forward this time unless new research could be presented to sway the state medical board’s decision. ” One Ohio Physician Embraces Cannabis Research But Denies Effectiveness . Research Shows to be Supportive Despite it All.

Conditions 98

Conditions Research and Development Pharmaceutical Clinical Trials 98

MMJ Recs

JULY 11, 2020

An alarmingly high number of deaths in many countries has led to researchers scrambling to find an effective treatment or cure for the disease. One recent study conducted in Canada looked at whether marijuana might be an option for coronavirus treatment. What about medical marijuana and coronavirus?

Research and Development 52

Research and Development Treatment Clinical Trials Therapy 52

TheAnswerPage

JANUARY 11, 2022

Are you able to answer your patients’ medical marijuana questions? During my tenure, I have found the medical marijuana educational gap to be one of the most significant educational gaps that impacts a very broad range of healthcare providers. million medical marijuana patients nationwide.

Patients 98

Patients Education Marijuana Therapy 98

CannaMD

OCTOBER 29, 2020

We’ve all heard the urban legend of sinister neighbors sneaking marijuana into the unsuspecting hands of innocent trick-or-treaters. As NBC puts it – in their aptly titled article, The Halloween Tale of Marijuana Handed Out to Trick-or-Treaters is as Real as a Ghost Story : This is a ridiculous and unfounded claim. Cannabis: 1.

Research and Development 92

Research and Development Blood Pressure Data Clinical Trials 92

Veriheal

JUNE 24, 2021

health official reportedly slammed “ongoing federal restrictions that are inhibiting research into marijuana”. The Senator stated that the NIH has been reporting on “potentially promising peer-reviewed clinical research” and asked for an update on how the NIH was planning to proceed and navigate issues. .

Research and Development 52

Research and Development Clinical Trials Treatment Access 52

MedicalJane

JUNE 29, 2018

The FDA announced in a press release on Monday that it had approved the “first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy.”. On June 26, 2018, the FDA granted approval of Epidiolex, a cannabidiol (CBD) oral solution, to GW Research Ltd (GW). Prior to this week, the U.S.

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

Medical marijuana laws have changed dramatically across the country in recent years, and now cannabis pharmaceuticals appear to be the next big leap forward in cannabis law reform. Medical Marijuana In Pill Form, With FDA Approval. The recent years have seen drastic marijuana law changes in several states.

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

The Joint Blog

NOVEMBER 26, 2019

Inhaling marijuana is associated with reductions in headache and migraine severity, according to a new study published in the Journal of Pain , and published by the National Institute of Health. The post Study: Inhaling Marijuana Associated With Reductions in Headache/Migraine Severity appeared first on TheJointBlog.

Clinical Trials 55

Clinical Trials Research and Development Marijuana Data 55

Cannabis Law Report

SEPTEMBER 6, 2021

Cannabis is safer and has less severe side effects in comparison to other treatment options. It also finds usage along with other treatments either to enhance their efficacy or to combat adverse side effects. 12 Overview of Clinical Research Suggesting the Benefits of Medical Cannabis Across Various Indications.

Chronic Pain 86

Chronic Pain Research and Development Clinical Trials Epilepsy 86

CannaMD

AUGUST 26, 2020

A new review published by scientific journal, Pharmacology Biochemistry and Behavior , has found that marijuana cannabinoid, CBD, is a “promising” therapy for treating cocaine dependence. Current Cocaine Treatments. As researchers point out: There is no gold standard pharmacological treatment for dependence on cocaine.

Therapy 98

Therapy CBD Research and Development Treatment 98

Cannabis Law Report

SEPTEMBER 23, 2022

Bronner’s, Law Enforcement Action Partnership (LEAP), New Approach, Heroic Hearts Project, Sacred Garden Community, the Indigenous Peyote Conservation Initiative (IPCI), Veterans Exploring Treatment Solutions (VETS), and local organizations and advocates. September 1, 2022.

Decriminalization 52

Decriminalization Advocacy Research and Development Education 52